

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.93768751 |
| 2 | synaptic vesicle maturation (GO:0016188) | 4.91500375 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.85070637 |
| 4 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.66382100 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.61681446 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.50206396 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.49221447 |
| 8 | regulation of synaptic vesicle transport (GO:1902803) | 4.19881508 |
| 9 | glutamate secretion (GO:0014047) | 4.15743524 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.10925387 |
| 11 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.03341376 |
| 12 | sodium ion export (GO:0071436) | 3.99681150 |
| 13 | activation of protein kinase A activity (GO:0034199) | 3.89970407 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.86863115 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 3.79404050 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.71163591 |
| 17 | neurotransmitter secretion (GO:0007269) | 3.63264895 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 3.58099507 |
| 19 | cell communication by electrical coupling (GO:0010644) | 3.56041487 |
| 20 | vocalization behavior (GO:0071625) | 3.54284810 |
| 21 | membrane depolarization during action potential (GO:0086010) | 3.47164073 |
| 22 | proline transport (GO:0015824) | 3.45679371 |
| 23 | regulation of ARF protein signal transduction (GO:0032012) | 3.43116667 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.26094943 |
| 25 | response to pheromone (GO:0019236) | 3.25618908 |
| 26 | protein localization to synapse (GO:0035418) | 3.24214421 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 3.19698727 |
| 28 | Golgi transport vesicle coating (GO:0048200) | 3.19698727 |
| 29 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.19659778 |
| 30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.17611588 |
| 31 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.09502452 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 3.08376815 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.08192370 |
| 34 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.07420964 |
| 35 | exploration behavior (GO:0035640) | 3.07116695 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04340028 |
| 37 | calcium ion-dependent exocytosis (GO:0017156) | 3.03719478 |
| 38 | synaptic vesicle endocytosis (GO:0048488) | 3.00686188 |
| 39 | potassium ion import (GO:0010107) | 2.99770159 |
| 40 | positive regulation of receptor recycling (GO:0001921) | 2.95708622 |
| 41 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93951095 |
| 42 | neuromuscular process controlling posture (GO:0050884) | 2.89903422 |
| 43 | vesicle transport along microtubule (GO:0047496) | 2.89226568 |
| 44 | neurotransmitter transport (GO:0006836) | 2.88303873 |
| 45 | neuronal action potential propagation (GO:0019227) | 2.88030894 |
| 46 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.85620853 |
| 47 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.85224803 |
| 48 | cerebellar Purkinje cell layer development (GO:0021680) | 2.84432481 |
| 49 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.82521039 |
| 50 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.82353858 |
| 51 | regulation of ARF GTPase activity (GO:0032312) | 2.82197774 |
| 52 | protein targeting to Golgi (GO:0000042) | 2.81126761 |
| 53 | layer formation in cerebral cortex (GO:0021819) | 2.80045279 |
| 54 | detection of calcium ion (GO:0005513) | 2.78791581 |
| 55 | glycine transport (GO:0015816) | 2.77624170 |
| 56 | NADH metabolic process (GO:0006734) | 2.76132592 |
| 57 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.75274237 |
| 58 | potassium ion homeostasis (GO:0055075) | 2.74357114 |
| 59 | striatum development (GO:0021756) | 2.72310698 |
| 60 | cell communication involved in cardiac conduction (GO:0086065) | 2.71436402 |
| 61 | regulation of neurotransmitter secretion (GO:0046928) | 2.71298189 |
| 62 | mannose metabolic process (GO:0006013) | 2.71173179 |
| 63 | axon cargo transport (GO:0008088) | 2.71110400 |
| 64 | membrane repolarization (GO:0086009) | 2.70629965 |
| 65 | histone H3-K36 demethylation (GO:0070544) | 2.70541315 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70185089 |
| 67 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.69935635 |
| 68 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.69935635 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68719145 |
| 70 | negative regulation of myotube differentiation (GO:0010832) | 2.68445236 |
| 71 | positive regulation of membrane potential (GO:0045838) | 2.67755628 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.67609008 |
| 73 | dopamine receptor signaling pathway (GO:0007212) | 2.67224645 |
| 74 | neuron cell-cell adhesion (GO:0007158) | 2.66799296 |
| 75 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.65748330 |
| 76 | detection of light stimulus involved in visual perception (GO:0050908) | 2.65425708 |
| 77 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.65425708 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 2.65138126 |
| 79 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.65006644 |
| 80 | synaptic transmission, glutamatergic (GO:0035249) | 2.64353942 |
| 81 | cellular sodium ion homeostasis (GO:0006883) | 2.62925200 |
| 82 | cellular response to epinephrine stimulus (GO:0071872) | 2.62552667 |
| 83 | establishment of protein localization to Golgi (GO:0072600) | 2.61906874 |
| 84 | response to muramyl dipeptide (GO:0032495) | 2.61294793 |
| 85 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.60786646 |
| 86 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.60575156 |
| 87 | innervation (GO:0060384) | 2.59717973 |
| 88 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.59530395 |
| 89 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.59394694 |
| 90 | insulin secretion (GO:0030073) | 2.58315270 |
| 91 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.58195630 |
| 92 | skeletal muscle adaptation (GO:0043501) | 2.57564420 |
| 93 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.54769575 |
| 94 | negative regulation of type 2 immune response (GO:0002829) | 2.54338481 |
| 95 | regulation of neurotransmitter levels (GO:0001505) | 2.54261453 |
| 96 | gamma-aminobutyric acid transport (GO:0015812) | 2.53511877 |
| 97 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.53504230 |
| 98 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53307309 |
| 99 | regulation of vesicle fusion (GO:0031338) | 2.53100142 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 2.52331073 |
| 101 | plasma membrane repair (GO:0001778) | 2.52282946 |
| 102 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.51547641 |
| 103 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.51476182 |
| 104 | organelle transport along microtubule (GO:0072384) | 2.51375390 |
| 105 | cellular response to monoamine stimulus (GO:0071868) | 2.49685742 |
| 106 | cellular response to catecholamine stimulus (GO:0071870) | 2.49685742 |
| 107 | membrane hyperpolarization (GO:0060081) | 2.48176816 |
| 108 | germinal center formation (GO:0002467) | 2.47819103 |
| 109 | macrophage activation involved in immune response (GO:0002281) | 2.47728246 |
| 110 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.47656493 |
| 111 | neuron-neuron synaptic transmission (GO:0007270) | 2.47338902 |
| 112 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.46660043 |
| 113 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.46147223 |
| 114 | positive regulation of vesicle fusion (GO:0031340) | 2.45086435 |
| 115 | positive regulation of Rap GTPase activity (GO:0032854) | 2.44345064 |
| 116 | long-term memory (GO:0007616) | 2.44147939 |
| 117 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.43437181 |
| 118 | membrane depolarization (GO:0051899) | 2.43425973 |
| 119 | negative regulation of cell size (GO:0045792) | 2.43275062 |
| 120 | positive regulation of sodium ion transport (GO:0010765) | 2.42765271 |
| 121 | regulation of leukocyte degranulation (GO:0043300) | 2.42748388 |
| 122 | chemosensory behavior (GO:0007635) | 2.42247888 |
| 123 | macroautophagy (GO:0016236) | 2.42026632 |
| 124 | regulation of membrane repolarization (GO:0060306) | 2.41586790 |
| 125 | adenosine receptor signaling pathway (GO:0001973) | 2.36331366 |
| 126 | positive regulation by symbiont of host defense response (GO:0052509) | 2.35058643 |
| 127 | modulation by symbiont of host defense response (GO:0052031) | 2.35058643 |
| 128 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.35058643 |
| 129 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.35058643 |
| 130 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.35058643 |
| 131 | modulation by symbiont of host immune response (GO:0052553) | 2.35058643 |
| 132 | protein localization to endosome (GO:0036010) | 2.34412389 |
| 133 | skeletal muscle contraction (GO:0003009) | 2.34364841 |
| 134 | signal complex assembly (GO:0007172) | 2.33977601 |
| 135 | barbed-end actin filament capping (GO:0051016) | 2.33403348 |
| 136 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.31878674 |
| 137 | actin filament polymerization (GO:0030041) | 2.31129269 |
| 138 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31119548 |
| 139 | regulation of platelet aggregation (GO:0090330) | 2.30970228 |
| 140 | histone H3-K9 demethylation (GO:0033169) | 2.29094939 |
| 141 | histone lysine demethylation (GO:0070076) | 2.28456387 |
| 142 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.28043665 |
| 143 | regulation of regulated secretory pathway (GO:1903305) | 2.27711429 |
| 144 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.24471907 |
| 145 | negative regulation of cell killing (GO:0031342) | 2.24471907 |
| 146 | response to peptidoglycan (GO:0032494) | 2.24123043 |
| 147 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.24121841 |
| 148 | striated muscle atrophy (GO:0014891) | 2.22811878 |
| 149 | cerebellar granule cell differentiation (GO:0021707) | 2.19156355 |
| 150 | receptor recycling (GO:0001881) | 2.17739335 |
| 151 | stress fiber assembly (GO:0043149) | 2.16218737 |
| 152 | regulation of necroptotic process (GO:0060544) | 2.15461499 |
| 153 | corticosteroid receptor signaling pathway (GO:0031958) | 2.14984446 |
| 154 | regulation of mast cell degranulation (GO:0043304) | 2.14550991 |
| 155 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.14177403 |
| 156 | histone demethylation (GO:0016577) | 2.14156455 |
| 157 | creatine metabolic process (GO:0006600) | 2.12930935 |
| 158 | megakaryocyte development (GO:0035855) | 2.12930589 |
| 159 | negative regulation of granulocyte differentiation (GO:0030853) | 2.12197421 |
| 160 | regulation of defense response to virus by virus (GO:0050690) | 2.12077264 |
| 161 | regulation of early endosome to late endosome transport (GO:2000641) | 2.10104020 |
| 162 | response to epinephrine (GO:0071871) | 2.08324512 |
| 163 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.07802991 |
| 164 | response to laminar fluid shear stress (GO:0034616) | 2.07725741 |
| 165 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.06925148 |
| 166 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.05476889 |
| 167 | protein targeting to plasma membrane (GO:0072661) | 2.05152172 |
| 168 | regulation of receptor recycling (GO:0001919) | 2.05058247 |
| 169 | cell-substrate adherens junction assembly (GO:0007045) | 2.04714652 |
| 170 | focal adhesion assembly (GO:0048041) | 2.04714652 |
| 171 | adherens junction assembly (GO:0034333) | 2.04519748 |
| 172 | activation of Rac GTPase activity (GO:0032863) | 2.04366526 |
| 173 | activation of JUN kinase activity (GO:0007257) | 2.03889281 |
| 174 | detection of molecule of bacterial origin (GO:0032490) | 2.02744051 |
| 175 | response to monoamine (GO:0071867) | 2.02400579 |
| 176 | response to catecholamine (GO:0071869) | 2.02400579 |
| 177 | regulation of interleukin-13 production (GO:0032656) | 2.02254669 |
| 178 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.01205250 |
| 179 | B cell receptor signaling pathway (GO:0050853) | 2.00880291 |
| 180 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.00613922 |
| 181 | platelet aggregation (GO:0070527) | 1.97783017 |
| 182 | regulation of Rap GTPase activity (GO:0032317) | 1.97390655 |
| 183 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 1.96686399 |
| 184 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 1.95612381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.13310909 |
| 2 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.68889400 |
| 3 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.63750481 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.61311189 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.45673044 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42116685 |
| 7 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.37677796 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.35004189 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24085547 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.20054445 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19890690 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.14643076 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.04999519 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.02910032 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.01252118 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 1.96907925 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95058960 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91026620 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.89752596 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83626406 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82349192 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.79625781 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78982658 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78344014 |
| 25 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78079749 |
| 26 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.76515071 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73867106 |
| 28 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.69823175 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.69479030 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68977573 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68977573 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67644660 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66614254 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64377717 |
| 35 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63277811 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63201986 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62883507 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62879473 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58746544 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58061795 |
| 41 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57369449 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.57368843 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56043598 |
| 44 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55559797 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54603742 |
| 46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54570248 |
| 47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.53552360 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49136418 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49067857 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48241999 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46684752 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46149151 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45951108 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43984634 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43159866 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41954095 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.41484269 |
| 58 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41056949 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39623491 |
| 60 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38647525 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37825718 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.35080226 |
| 63 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.34345889 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33528878 |
| 65 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.33526522 |
| 66 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.32100356 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31257791 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31175487 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30251539 |
| 70 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28550858 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28348339 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27977792 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27375325 |
| 74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26842557 |
| 75 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.26095472 |
| 76 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25996158 |
| 77 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.25781846 |
| 78 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25528169 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.25283867 |
| 80 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.23970989 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23205897 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22733079 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21854672 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19977031 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19865672 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19577238 |
| 87 | AR_19668381_ChIP-Seq_PC3_Human | 1.18144544 |
| 88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17688413 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16137939 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15767536 |
| 91 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.15492532 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13917228 |
| 93 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12960095 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12927314 |
| 95 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12464876 |
| 96 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12115552 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.10832991 |
| 98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10623368 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09617969 |
| 100 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09551529 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 1.09224458 |
| 102 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.09211626 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09074389 |
| 104 | MAF_26560356_Chip-Seq_TH2_Human | 1.07207340 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07191907 |
| 106 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06600973 |
| 107 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06167642 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02700742 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01946807 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01704296 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01414397 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01133223 |
| 113 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.01069383 |
| 114 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00746893 |
| 115 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.00682006 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00009251 |
| 117 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98890423 |
| 118 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.98553018 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97905319 |
| 120 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97460243 |
| 121 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97268430 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97264910 |
| 123 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97170763 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96940235 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94891284 |
| 126 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94624539 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94612251 |
| 128 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94373764 |
| 129 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93978742 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93960277 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92595434 |
| 132 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91326004 |
| 133 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91057198 |
| 134 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.90882665 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90674871 |
| 136 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90626108 |
| 137 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88970325 |
| 138 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88927430 |
| 139 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88378880 |
| 140 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.87704307 |
| 141 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87325678 |
| 142 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87237444 |
| 143 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87037765 |
| 144 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.86797622 |
| 145 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86372320 |
| 146 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85833968 |
| 147 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.85809713 |
| 148 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85759370 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85288159 |
| 150 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85107757 |
| 151 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85107757 |
| 152 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84714342 |
| 153 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84477100 |
| 154 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84228469 |
| 155 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83522809 |
| 156 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.83451989 |
| 157 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83340997 |
| 158 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83330957 |
| 159 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83112719 |
| 160 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81917074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.74082433 |
| 2 | MP0005451_abnormal_body_composition | 3.16799272 |
| 3 | MP0005464_abnormal_platelet_physiology | 3.10007900 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.04836669 |
| 5 | MP0004270_analgesia | 2.88058376 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 2.85096199 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.61740367 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.61328680 |
| 9 | MP0008260_abnormal_autophagy | 2.57858132 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.54676604 |
| 11 | MP0000751_myopathy | 2.49193066 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.45321930 |
| 13 | MP0003303_peritoneal_inflammation | 2.40566592 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.30902696 |
| 15 | MP0009046_muscle_twitch | 2.29518005 |
| 16 | MP0002064_seizures | 2.22997450 |
| 17 | MP0009745_abnormal_behavioral_response | 2.22668294 |
| 18 | MP0004858_abnormal_nervous_system | 2.21812164 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.12609032 |
| 20 | MP0003880_abnormal_central_pattern | 2.11821138 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.11559074 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.11191015 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.05841891 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.04190849 |
| 25 | MP0000013_abnormal_adipose_tissue | 2.03989632 |
| 26 | MP0004233_abnormal_muscle_weight | 2.00463122 |
| 27 | MP0002736_abnormal_nociception_after | 1.99531013 |
| 28 | MP0002822_catalepsy | 1.98042331 |
| 29 | MP0003436_decreased_susceptibility_to | 1.95488836 |
| 30 | MP0002272_abnormal_nervous_system | 1.91874052 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.90191990 |
| 32 | MP0009278_abnormal_bone_marrow | 1.88598080 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 1.85863705 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.80987907 |
| 35 | MP0005409_darkened_coat_color | 1.80559931 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.79185646 |
| 37 | MP0003646_muscle_fatigue | 1.77221815 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.73465861 |
| 39 | MP0001970_abnormal_pain_threshold | 1.73276629 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.71387399 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.66798012 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.65083142 |
| 43 | MP0004130_abnormal_muscle_cell | 1.64948925 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.60575354 |
| 45 | MP0008569_lethality_at_weaning | 1.59664430 |
| 46 | MP0004043_abnormal_pH_regulation | 1.59093157 |
| 47 | MP0003091_abnormal_cell_migration | 1.57302684 |
| 48 | MP0002653_abnormal_ependyma_morphology | 1.56965738 |
| 49 | MP0008004_abnormal_stomach_pH | 1.54021698 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.51916140 |
| 51 | MP0003724_increased_susceptibility_to | 1.51854800 |
| 52 | MP0003329_amyloid_beta_deposits | 1.51316752 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.51092649 |
| 54 | MP0005410_abnormal_fertilization | 1.50544021 |
| 55 | MP0003690_abnormal_glial_cell | 1.50345542 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.50114326 |
| 57 | MP0003879_abnormal_hair_cell | 1.48477329 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.48312713 |
| 59 | MP0004947_skin_inflammation | 1.47851834 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.45973679 |
| 61 | MP0003787_abnormal_imprinting | 1.44986919 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.44292536 |
| 63 | MP0005670_abnormal_white_adipose | 1.43472139 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.42426658 |
| 65 | MP0003828_pulmonary_edema | 1.38859777 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.36561254 |
| 67 | MP0005253_abnormal_eye_physiology | 1.35994134 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.35104797 |
| 69 | MP0008874_decreased_physiological_sensi | 1.35048156 |
| 70 | MP0003122_maternal_imprinting | 1.33626530 |
| 71 | MP0003633_abnormal_nervous_system | 1.31987159 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.31908706 |
| 73 | MP0004036_abnormal_muscle_relaxation | 1.31296365 |
| 74 | MP0003283_abnormal_digestive_organ | 1.28413761 |
| 75 | MP0001984_abnormal_olfaction | 1.27561774 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.26710218 |
| 77 | MP0001486_abnormal_startle_reflex | 1.26656414 |
| 78 | MP0000955_abnormal_spinal_cord | 1.25978728 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.25613823 |
| 80 | MP0005083_abnormal_biliary_tract | 1.25104401 |
| 81 | MP0009840_abnormal_foam_cell | 1.24099135 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.23920372 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.22429607 |
| 84 | MP0004924_abnormal_behavior | 1.22429607 |
| 85 | MP0002184_abnormal_innervation | 1.20633258 |
| 86 | MP0002419_abnormal_innate_immunity | 1.19676548 |
| 87 | MP0002229_neurodegeneration | 1.19345376 |
| 88 | MP0002882_abnormal_neuron_morphology | 1.19094856 |
| 89 | MP0001502_abnormal_circadian_rhythm | 1.18518634 |
| 90 | MP0000749_muscle_degeneration | 1.18423358 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 1.18222736 |
| 92 | MP0000747_muscle_weakness | 1.17834325 |
| 93 | MP0003045_fibrosis | 1.17817403 |
| 94 | MP0002009_preneoplasia | 1.16497130 |
| 95 | MP0003075_altered_response_to | 1.16370868 |
| 96 | MP0006276_abnormal_autonomic_nervous | 1.13949526 |
| 97 | MP0000003_abnormal_adipose_tissue | 1.13375342 |
| 98 | MP0001545_abnormal_hematopoietic_system | 1.12981534 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 1.12981534 |
| 100 | MP0000604_amyloidosis | 1.12502468 |
| 101 | MP0001440_abnormal_grooming_behavior | 1.12427895 |
| 102 | MP0005025_abnormal_response_to | 1.11824021 |
| 103 | MP0001835_abnormal_antigen_presentation | 1.11068593 |
| 104 | MP0003866_abnormal_defecation | 1.10870954 |
| 105 | MP0005645_abnormal_hypothalamus_physiol | 1.10804019 |
| 106 | MP0002693_abnormal_pancreas_physiology | 1.09927313 |
| 107 | MP0002971_abnormal_brown_adipose | 1.09416604 |
| 108 | MP0004084_abnormal_cardiac_muscle | 1.09203409 |
| 109 | MP0002557_abnormal_social/conspecific_i | 1.07908652 |
| 110 | MP0002269_muscular_atrophy | 1.07695218 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 1.06325615 |
| 112 | MP0002066_abnormal_motor_capabilities/c | 1.06167722 |
| 113 | MP0002106_abnormal_muscle_physiology | 1.02328884 |
| 114 | MP0005535_abnormal_body_temperature | 1.01757653 |
| 115 | MP0001849_ear_inflammation | 1.01593602 |
| 116 | MP0004381_abnormal_hair_follicle | 1.00411755 |
| 117 | MP0004085_abnormal_heartbeat | 1.00394431 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.99775503 |
| 119 | MP0004484_altered_response_of | 0.99206644 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.98616668 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.96338650 |
| 122 | MP0002090_abnormal_vision | 0.96294445 |
| 123 | MP0003631_nervous_system_phenotype | 0.95863072 |
| 124 | MP0001944_abnormal_pancreas_morphology | 0.95016832 |
| 125 | MP0004147_increased_porphyrin_level | 0.94027127 |
| 126 | MP0001800_abnormal_humoral_immune | 0.93578310 |
| 127 | MP0010155_abnormal_intestine_physiology | 0.93031079 |
| 128 | MP0005000_abnormal_immune_tolerance | 0.91576996 |
| 129 | MP0004885_abnormal_endolymph | 0.91461266 |
| 130 | MP0002877_abnormal_melanocyte_morpholog | 0.91149780 |
| 131 | MP0005310_abnormal_salivary_gland | 0.90381187 |
| 132 | MP0000685_abnormal_immune_system | 0.89691932 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.89115076 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.88761047 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.88693942 |
| 136 | MP0002723_abnormal_immune_serum | 0.88064205 |
| 137 | MP0005621_abnormal_cell_physiology | 0.87149464 |
| 138 | MP0002234_abnormal_pharynx_morphology | 0.86873312 |
| 139 | MP0000733_abnormal_muscle_development | 0.86230845 |
| 140 | MP0001851_eye_inflammation | 0.86090421 |
| 141 | MP0001533_abnormal_skeleton_physiology | 0.85954415 |
| 142 | MP0002069_abnormal_eating/drinking_beha | 0.85928426 |
| 143 | MP0000015_abnormal_ear_pigmentation | 0.85642197 |
| 144 | MP0002420_abnormal_adaptive_immunity | 0.85521379 |
| 145 | MP0002638_abnormal_pupillary_reflex | 0.85225483 |
| 146 | MP0005448_abnormal_energy_balance | 0.84876932 |
| 147 | MP0003634_abnormal_glial_cell | 0.84602738 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.84290840 |
| 149 | MP0004510_myositis | 0.84088430 |
| 150 | MP0001819_abnormal_immune_cell | 0.83642216 |
| 151 | MP0002398_abnormal_bone_marrow | 0.82910853 |
| 152 | MP0000920_abnormal_myelination | 0.82772858 |
| 153 | MP0010630_abnormal_cardiac_muscle | 0.81619430 |
| 154 | MP0002452_abnormal_antigen_presenting | 0.80982662 |
| 155 | MP0005620_abnormal_muscle_contractility | 0.80472966 |
| 156 | MP0001790_abnormal_immune_system | 0.80388043 |
| 157 | MP0005387_immune_system_phenotype | 0.80388043 |
| 158 | MP0004808_abnormal_hematopoietic_stem | 0.80375642 |
| 159 | MP0000858_altered_metastatic_potential | 0.80151777 |
| 160 | MP0000759_abnormal_skeletal_muscle | 0.79895043 |
| 161 | MP0000249_abnormal_blood_vessel | 0.79512500 |
| 162 | MP0005666_abnormal_adipose_tissue | 0.76345406 |
| 163 | MP0003137_abnormal_impulse_conducting | 0.75812247 |
| 164 | MP0004087_abnormal_muscle_fiber | 0.74164729 |
| 165 | MP0001664_abnormal_digestion | 0.73237482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Visual hallucinations (HP:0002367) | 4.72432909 |
| 2 | Congenital stationary night blindness (HP:0007642) | 4.30997016 |
| 3 | Myokymia (HP:0002411) | 4.17259082 |
| 4 | Focal motor seizures (HP:0011153) | 3.96897155 |
| 5 | Central scotoma (HP:0000603) | 3.68990387 |
| 6 | Focal seizures (HP:0007359) | 3.61547455 |
| 7 | Prolonged bleeding time (HP:0003010) | 3.46709815 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.38871989 |
| 9 | Atonic seizures (HP:0010819) | 3.34783585 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.32895721 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.19680254 |
| 12 | Distal lower limb amyotrophy (HP:0008944) | 3.19122249 |
| 13 | Obstructive sleep apnea (HP:0002870) | 3.15193079 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.11322513 |
| 15 | Exercise-induced myalgia (HP:0003738) | 3.05816467 |
| 16 | Febrile seizures (HP:0002373) | 3.04935426 |
| 17 | Depression (HP:0000716) | 3.04284170 |
| 18 | Pheochromocytoma (HP:0002666) | 2.98305160 |
| 19 | Eczematoid dermatitis (HP:0000976) | 2.98294901 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 2.93872001 |
| 21 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.89278355 |
| 22 | Action tremor (HP:0002345) | 2.87989164 |
| 23 | Ankle clonus (HP:0011448) | 2.87660945 |
| 24 | Increased connective tissue (HP:0009025) | 2.85827080 |
| 25 | Postural instability (HP:0002172) | 2.78615112 |
| 26 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.78297346 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 2.77762343 |
| 28 | Absence seizures (HP:0002121) | 2.70920435 |
| 29 | Muscle fiber inclusion bodies (HP:0100299) | 2.68615281 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 2.68091052 |
| 31 | Bundle branch block (HP:0011710) | 2.63470132 |
| 32 | Nemaline bodies (HP:0003798) | 2.63091889 |
| 33 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.62189515 |
| 34 | Generalized tonic-clonic seizures (HP:0002069) | 2.60772794 |
| 35 | Abnormality of macular pigmentation (HP:0008002) | 2.58593012 |
| 36 | Epistaxis (HP:0000421) | 2.58571949 |
| 37 | Hypercortisolism (HP:0001578) | 2.57903315 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.57582994 |
| 39 | Gingival bleeding (HP:0000225) | 2.56913248 |
| 40 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.54980883 |
| 41 | Menorrhagia (HP:0000132) | 2.52951534 |
| 42 | Dysmetric saccades (HP:0000641) | 2.51038948 |
| 43 | Poor eye contact (HP:0000817) | 2.47710344 |
| 44 | Purpura (HP:0000979) | 2.47258864 |
| 45 | Impaired social interactions (HP:0000735) | 2.46355944 |
| 46 | Abnormal social behavior (HP:0012433) | 2.46355944 |
| 47 | Lower limb amyotrophy (HP:0007210) | 2.45543131 |
| 48 | Dialeptic seizures (HP:0011146) | 2.45316771 |
| 49 | Truncal ataxia (HP:0002078) | 2.44164867 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.43920403 |
| 51 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.43086418 |
| 52 | Colitis (HP:0002583) | 2.41175375 |
| 53 | Scotoma (HP:0000575) | 2.40957181 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.40358569 |
| 55 | Broad face (HP:0000283) | 2.40346492 |
| 56 | Muscle fiber splitting (HP:0003555) | 2.38989989 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.38912587 |
| 58 | Myopathic facies (HP:0002058) | 2.36690554 |
| 59 | Type 1 muscle fiber predominance (HP:0003803) | 2.36227022 |
| 60 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.35366025 |
| 61 | Failure to thrive in infancy (HP:0001531) | 2.35268366 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.34101340 |
| 63 | Resting tremor (HP:0002322) | 2.33791490 |
| 64 | Ventricular fibrillation (HP:0001663) | 2.32599790 |
| 65 | Anxiety (HP:0000739) | 2.31815562 |
| 66 | Abnormal eating behavior (HP:0100738) | 2.30235962 |
| 67 | Oligomenorrhea (HP:0000876) | 2.28720301 |
| 68 | Petechiae (HP:0000967) | 2.27861561 |
| 69 | Slow saccadic eye movements (HP:0000514) | 2.26140957 |
| 70 | Menstrual irregularities (HP:0000858) | 2.25010829 |
| 71 | Abnormal platelet volume (HP:0011876) | 2.24449404 |
| 72 | Neoplasm of the heart (HP:0100544) | 2.23431932 |
| 73 | Insomnia (HP:0100785) | 2.20037804 |
| 74 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18318555 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.17854228 |
| 76 | Urinary urgency (HP:0000012) | 2.17447686 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.16674313 |
| 78 | Bradykinesia (HP:0002067) | 2.16505591 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 2.15635636 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 2.15003079 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.14885136 |
| 82 | Myoglobinuria (HP:0002913) | 2.14555582 |
| 83 | Cellulitis (HP:0100658) | 2.13744072 |
| 84 | Hemiplegia (HP:0002301) | 2.13260006 |
| 85 | Foot dorsiflexor weakness (HP:0009027) | 2.13141883 |
| 86 | Difficulty running (HP:0009046) | 2.12746526 |
| 87 | Hand muscle atrophy (HP:0009130) | 2.12125232 |
| 88 | Large for gestational age (HP:0001520) | 2.12103907 |
| 89 | Dysdiadochokinesis (HP:0002075) | 2.11620635 |
| 90 | Spontaneous hematomas (HP:0007420) | 2.11358057 |
| 91 | Type II diabetes mellitus (HP:0005978) | 2.09903122 |
| 92 | Subaortic stenosis (HP:0001682) | 2.09682813 |
| 93 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.09682813 |
| 94 | Neurofibrillary tangles (HP:0002185) | 2.08344497 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.08319645 |
| 96 | Dysostosis multiplex (HP:0000943) | 2.08222988 |
| 97 | Increased mean platelet volume (HP:0011877) | 2.07551488 |
| 98 | Ulnar deviation of the wrist (HP:0003049) | 2.06743938 |
| 99 | Impaired smooth pursuit (HP:0007772) | 2.06424847 |
| 100 | Gingivitis (HP:0000230) | 2.06305163 |
| 101 | Abnormality of macrophages (HP:0004311) | 2.03238753 |
| 102 | Myotonia (HP:0002486) | 2.02878274 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.02268434 |
| 104 | Difficulty climbing stairs (HP:0003551) | 2.01590337 |
| 105 | Growth hormone excess (HP:0000845) | 2.00797947 |
| 106 | Hypoventilation (HP:0002791) | 2.00495703 |
| 107 | EMG: myopathic abnormalities (HP:0003458) | 2.00361102 |
| 108 | Prolonged QT interval (HP:0001657) | 1.99001525 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98611388 |
| 110 | Hemorrhage of the eye (HP:0011885) | 1.98257594 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.98075085 |
| 112 | Distal upper limb amyotrophy (HP:0007149) | 1.98075085 |
| 113 | Agitation (HP:0000713) | 1.97509523 |
| 114 | Rapidly progressive (HP:0003678) | 1.97277865 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.96894734 |
| 116 | Papilledema (HP:0001085) | 1.96591569 |
| 117 | Choroideremia (HP:0001139) | 1.96440664 |
| 118 | Onion bulb formation (HP:0003383) | 1.94118267 |
| 119 | Abnormality of pain sensation (HP:0010832) | 1.93126134 |
| 120 | Impaired pain sensation (HP:0007328) | 1.93126134 |
| 121 | Abnormality of the foot musculature (HP:0001436) | 1.92398317 |
| 122 | Inflammation of the large intestine (HP:0002037) | 1.92291991 |
| 123 | Spastic gait (HP:0002064) | 1.92130175 |
| 124 | Long toe (HP:0010511) | 1.90687093 |
| 125 | Spinal canal stenosis (HP:0003416) | 1.90210313 |
| 126 | Abnormal EKG (HP:0003115) | 1.90010684 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.89357563 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89357563 |
| 129 | Recurrent abscess formation (HP:0002722) | 1.87082832 |
| 130 | Increased IgE level (HP:0003212) | 1.86088447 |
| 131 | Gaze-evoked nystagmus (HP:0000640) | 1.86010447 |
| 132 | Genetic anticipation (HP:0003743) | 1.85916980 |
| 133 | Flat acetabular roof (HP:0003180) | 1.85856783 |
| 134 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.85281554 |
| 135 | Bulbar palsy (HP:0001283) | 1.84838106 |
| 136 | Scanning speech (HP:0002168) | 1.84489173 |
| 137 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.84018958 |
| 138 | Polyphagia (HP:0002591) | 1.83955440 |
| 139 | Progressive sensorineural hearing impairment (HP:0000408) | 1.83454731 |
| 140 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.81627542 |
| 141 | Recurrent bacterial skin infections (HP:0005406) | 1.80830277 |
| 142 | Hyperkalemia (HP:0002153) | 1.80818545 |
| 143 | Mutism (HP:0002300) | 1.80241773 |
| 144 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79928936 |
| 145 | Decreased motor nerve conduction velocity (HP:0003431) | 1.79765940 |
| 146 | Amyotrophic lateral sclerosis (HP:0007354) | 1.78096605 |
| 147 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78027051 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78027051 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78027051 |
| 150 | Lower limb muscle weakness (HP:0007340) | 1.77730261 |
| 151 | Ketoacidosis (HP:0001993) | 1.77556961 |
| 152 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.77351773 |
| 153 | Hyperacusis (HP:0010780) | 1.76505280 |
| 154 | Loss of speech (HP:0002371) | 1.73794596 |
| 155 | Rhabdomyolysis (HP:0003201) | 1.73201688 |
| 156 | Bowel incontinence (HP:0002607) | 1.72376801 |
| 157 | Sudden death (HP:0001699) | 1.71915630 |
| 158 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71547257 |
| 159 | Dysmetria (HP:0001310) | 1.71515182 |
| 160 | Neuronal loss in central nervous system (HP:0002529) | 1.71340549 |
| 161 | Clonus (HP:0002169) | 1.69743018 |
| 162 | Torticollis (HP:0000473) | 1.68880368 |
| 163 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.68499408 |
| 164 | Exercise-induced muscle cramps (HP:0003710) | 1.68487346 |
| 165 | Diplopia (HP:0000651) | 1.68309951 |
| 166 | Abnormality of binocular vision (HP:0011514) | 1.68309951 |
| 167 | Psychosis (HP:0000709) | 1.68254739 |
| 168 | Dyschromatopsia (HP:0007641) | 1.67292400 |
| 169 | Rigidity (HP:0002063) | 1.66843005 |
| 170 | Frequent falls (HP:0002359) | 1.66691213 |
| 171 | Round ear (HP:0100830) | 1.66345345 |
| 172 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.66138414 |
| 173 | Thoracic kyphosis (HP:0002942) | 1.65942902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRKD3 | 4.33219027 |
| 2 | NTRK3 | 2.97352056 |
| 3 | MAP3K9 | 2.90491847 |
| 4 | TRIB3 | 2.43788296 |
| 5 | MAP3K4 | 2.26614445 |
| 6 | ERN1 | 2.25394848 |
| 7 | SIK1 | 2.25332676 |
| 8 | MINK1 | 2.19620434 |
| 9 | CDK12 | 2.16332589 |
| 10 | PAK6 | 2.15757583 |
| 11 | PDK4 | 2.00760155 |
| 12 | PDK3 | 2.00760155 |
| 13 | LMTK2 | 1.89677083 |
| 14 | KSR2 | 1.88226491 |
| 15 | PHKG2 | 1.81679285 |
| 16 | PHKG1 | 1.81679285 |
| 17 | CAMKK1 | 1.81118625 |
| 18 | STK38 | 1.81064890 |
| 19 | MAP2K3 | 1.75525693 |
| 20 | EPHB1 | 1.73908376 |
| 21 | EEF2K | 1.73327314 |
| 22 | DAPK2 | 1.71341554 |
| 23 | NTRK1 | 1.70559055 |
| 24 | TAOK1 | 1.55188428 |
| 25 | MARK1 | 1.55112226 |
| 26 | BLK | 1.53638061 |
| 27 | CAMKK2 | 1.51235938 |
| 28 | PINK1 | 1.49662054 |
| 29 | MAP2K4 | 1.49121420 |
| 30 | OBSCN | 1.40399248 |
| 31 | PRKCH | 1.40013221 |
| 32 | ICK | 1.35463739 |
| 33 | CCNB1 | 1.31088696 |
| 34 | CAMK1G | 1.27234639 |
| 35 | MAP2K7 | 1.27083437 |
| 36 | RET | 1.26942412 |
| 37 | MAP3K2 | 1.26098961 |
| 38 | MAP3K12 | 1.24976625 |
| 39 | DAPK1 | 1.16713697 |
| 40 | CDK5 | 1.15070377 |
| 41 | MAP3K11 | 1.12808973 |
| 42 | FGFR4 | 1.10065042 |
| 43 | SMG1 | 1.08765019 |
| 44 | MAPK13 | 1.08209866 |
| 45 | BMX | 1.07824345 |
| 46 | NTRK2 | 1.07464789 |
| 47 | CSF1R | 1.07386605 |
| 48 | INSRR | 1.06619255 |
| 49 | PKN2 | 1.06120387 |
| 50 | EPHA4 | 1.05954554 |
| 51 | PDK1 | 1.04670292 |
| 52 | BTK | 1.02690642 |
| 53 | NEK1 | 1.02077496 |
| 54 | SGK223 | 1.01725608 |
| 55 | SGK494 | 1.01725608 |
| 56 | SCYL2 | 1.01596966 |
| 57 | MAP3K1 | 1.01478667 |
| 58 | CDK19 | 1.01442794 |
| 59 | SGK3 | 1.00192406 |
| 60 | MAP2K6 | 0.99109729 |
| 61 | GRK5 | 0.98882493 |
| 62 | PTK2B | 0.98318569 |
| 63 | MAPK11 | 0.96340679 |
| 64 | PDPK1 | 0.96056875 |
| 65 | RIPK4 | 0.93837046 |
| 66 | SIK2 | 0.92949343 |
| 67 | TBK1 | 0.92856555 |
| 68 | MARK2 | 0.92731106 |
| 69 | PRPF4B | 0.91533648 |
| 70 | CAMK1D | 0.91300872 |
| 71 | TAOK2 | 0.90146848 |
| 72 | DYRK1B | 0.89297359 |
| 73 | RIPK1 | 0.88331900 |
| 74 | RPS6KA2 | 0.87347995 |
| 75 | GRK6 | 0.87325482 |
| 76 | MST1R | 0.85801936 |
| 77 | MTOR | 0.85790776 |
| 78 | SGK2 | 0.84833463 |
| 79 | IRAK3 | 0.83250143 |
| 80 | MAPKAPK3 | 0.82018873 |
| 81 | TTN | 0.81090859 |
| 82 | WNK4 | 0.79896995 |
| 83 | ARAF | 0.79507223 |
| 84 | IRAK4 | 0.79336161 |
| 85 | MAP3K3 | 0.79207896 |
| 86 | HCK | 0.79024518 |
| 87 | TESK1 | 0.78379919 |
| 88 | UHMK1 | 0.77471921 |
| 89 | IRAK2 | 0.76829441 |
| 90 | JAK1 | 0.75995383 |
| 91 | CAMK1 | 0.75774689 |
| 92 | SYK | 0.73546462 |
| 93 | PRKCG | 0.73324356 |
| 94 | PIK3CG | 0.72204617 |
| 95 | PDK2 | 0.70750391 |
| 96 | FES | 0.70421469 |
| 97 | SIK3 | 0.70347015 |
| 98 | PRKAA1 | 0.68847184 |
| 99 | TYK2 | 0.68539970 |
| 100 | CDC42BPA | 0.68520415 |
| 101 | HIPK2 | 0.67591920 |
| 102 | MAP3K13 | 0.67344173 |
| 103 | MAP3K7 | 0.66825494 |
| 104 | TYRO3 | 0.66683921 |
| 105 | JAK2 | 0.66244768 |
| 106 | STK11 | 0.65756083 |
| 107 | FGR | 0.65644073 |
| 108 | KSR1 | 0.64299608 |
| 109 | NEK6 | 0.63155177 |
| 110 | WNK1 | 0.63118632 |
| 111 | TESK2 | 0.62637369 |
| 112 | EPHA2 | 0.62524295 |
| 113 | TNK2 | 0.62068471 |
| 114 | PAK3 | 0.61433329 |
| 115 | PDGFRA | 0.61070796 |
| 116 | MAPK7 | 0.58644310 |
| 117 | TRPM7 | 0.57665802 |
| 118 | CDK15 | 0.53876596 |
| 119 | CSK | 0.53676502 |
| 120 | CDK18 | 0.53014494 |
| 121 | ALK | 0.52556574 |
| 122 | RPS6KC1 | 0.52176771 |
| 123 | RPS6KL1 | 0.52176771 |
| 124 | PRKCZ | 0.51993939 |
| 125 | CAMK2A | 0.51845322 |
| 126 | PTK6 | 0.51635425 |
| 127 | FGFR3 | 0.51376923 |
| 128 | PRKD2 | 0.50952234 |
| 129 | EPHA3 | 0.49648425 |
| 130 | PRKD1 | 0.49056667 |
| 131 | MAP2K1 | 0.49005469 |
| 132 | SGK1 | 0.48624056 |
| 133 | IKBKE | 0.46868062 |
| 134 | RPS6KA3 | 0.46285576 |
| 135 | CDK14 | 0.45714440 |
| 136 | CAMK4 | 0.43977478 |
| 137 | CDK11A | 0.43173084 |
| 138 | MAPK12 | 0.42879147 |
| 139 | MAP3K14 | 0.42193055 |
| 140 | ZAP70 | 0.41971458 |
| 141 | MAP3K6 | 0.40508898 |
| 142 | TAOK3 | 0.39108872 |
| 143 | RAF1 | 0.38718625 |
| 144 | MAP4K1 | 0.36465451 |
| 145 | PASK | 0.35648005 |
| 146 | MAPK10 | 0.35629045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.33757687 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.60632719 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.30779817 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.26533455 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.06092785 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02483259 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02321261 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.98338617 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96238451 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.88677425 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87569193 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77210692 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.76290509 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.74842533 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.69832204 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65677220 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64592905 |
| 18 | Platelet activation_Homo sapiens_hsa04611 | 1.63734810 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.63247171 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61631964 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.61610023 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.60548345 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.60278083 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60011043 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59604984 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59309369 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.53813409 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52395691 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51728423 |
| 30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.44728135 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42505849 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.42021837 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37858388 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36651529 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.33577590 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32234127 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30872879 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.30085771 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27555790 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27242638 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26489508 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26021575 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23154911 |
| 44 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.19033269 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.16109062 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15072776 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13933909 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13338808 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12345916 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09905760 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09710162 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.08223121 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06921677 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04461283 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02400585 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01719329 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 0.99462000 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 0.99014955 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98275138 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97289905 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.96403819 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.94189650 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93725983 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.93328964 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92354445 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91672838 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91664850 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90269675 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89314924 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89157796 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.85259317 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85058583 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84508981 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84088629 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82640461 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82426242 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82417361 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.81151094 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79599466 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79525014 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.79355339 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79334082 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77669096 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75981427 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75278038 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.74513541 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73994247 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73023526 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72971941 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72865184 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72181950 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.71082349 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.69202841 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68630395 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67704628 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67359894 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66189483 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.65945811 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65734442 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64094173 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.63748540 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63713634 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62856761 |
| 104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62102029 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61367787 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.60845701 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.59528569 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.58763119 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58597449 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57579147 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57194845 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.57148858 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56846244 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56576154 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53558622 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51318240 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51298805 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51062334 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50030245 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49397479 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48392658 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47152250 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47116636 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46846578 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45290989 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44827293 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44441120 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42058820 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40088152 |
| 130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38585295 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37512496 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37480565 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35717728 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35693710 |

